Skip to content

Combined Effect of Tinospora cordifolia and Urtica urens Q versus allopathic medicine (allopurinol/febuxostat) in the treatment of hyperuricemia

A randomized controlled trial: Combined Effect of Tinospora cordifolia and Urtica urens Q versus allopathic medicine (allopurinol/febuxostat) in the treatment of hyperuricemia

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053359
Enrollment
72
Registered
2023-06-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease Health Condition 2: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease

Interventions

None listed

Sponsors

NORTH EASTERN INSTITUTE OF AYURVEDA AND HOMOEOPATHY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Males and females belonging to North East India. 2. Males and Females aged 30-60 years 3. Cases with Diabetes mellitus and Hypertension will be included.

Exclusion criteria

Exclusion criteria: 1. Persons suffering from any chronic disease e.g. malignancy or organic deformity etc. 2. Pregnant and lactating females

Design outcomes

Primary

MeasureTime frame
Combined application of Ayurvedic medicine Tinospora cordifolia and Homoeopathic medicine Urtica urens mother tincture helps in lowering the serum uric acid level.Timepoint: Baseline, 30days, 60 days

Secondary

MeasureTime frame
No side effects on combined application of tinospora cordifolia and urtica urens QTimepoint: baseline, 30 days, 60 days

Countries

India

Contacts

Public ContactDr Neeta Mahesekar

North Eastern Institute of Ayurveda and Homoeopathy

neeta_mahesekar@yahoo.com9822627092

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026